Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -79,273 | -47,497 | -26,708 | -66,388 | -45,837 |
| Depreciation Amortization | 43 | 24 | 10 | 21 | 15 |
| Accounts payable and accrued liabilities | 914 | 4,737 | 6,811 | 1,211 | 2,792 |
| Other Working Capital | 3,868 | 1,890 | 8,741 | 4,806 | 9,282 |
| Other Operating Activity | 13,617 | 2,830 | -2,652 | 6,993 | 3,441 |
| Operating Cash Flow | $-60,831 | $-38,016 | $-13,798 | $-53,357 | $-30,307 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -115 | -86 | -47 | -31 | -21 |
| Investing Cash Flow | $-115 | $-86 | $-47 | $-31 | $-21 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 7,907 | 7,907 |
| Debt Issued | N/A | N/A | N/A | 35,000 | 35,000 |
| Debt Repayment | -3,190 | N/A | N/A | -2,500 | -2,500 |
| Common Stock Issued | 386,442 | 385,717 | 196,845 | 1 | N/A |
| Other Financing Activity | -903 | -3,814 | -3,292 | 106,566 | 106,466 |
| Financing Cash Flow | $382,349 | $381,903 | $193,553 | $146,974 | $146,873 |
| Beginning Cash Position | 100,571 | 100,571 | 100,571 | 6,985 | 6,985 |
| End Cash Position | 421,974 | 444,372 | 280,279 | 100,571 | 123,530 |
| Net Cash Flow | $321,403 | $343,801 | $179,708 | $93,586 | $116,545 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,831 | -38,016 | -13,798 | -53,357 | -30,307 |
| Capital Expenditure | -115 | -86 | -47 | -31 | -21 |
| Free Cash Flow | -60,946 | -38,102 | -13,845 | -53,388 | -30,328 |